Stock Analiz

Cytokinetics Inc. (CYTK) stock forecast and price target

Price $56.13 · data as of November 13, 2026

12-month price target

Average target$109.42
Upside / downside+94.9%
Analysts19
ConsensusStrong buy
Low $78.00Average $109.42High $146.00

Gold marker: average target · white marker: today’s price ($56.13)

Analyst ratings

Strong buy 7Buy 13Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-5.76+11.9%$165M
Next fiscal year
ends December 31, 2027
$-4.23+26.6%$443M
Next quarter
ends December 31, 2026
$-1.35+9.9%$65M
Quarter after
ends March 31, 2027
$-1.28+23.2%$75M

Consensus of the analysts covering Cytokinetics, updated daily. In the last 30 days 8 estimates were raised and 2 lowered.

Frequently asked questions

What is the Cytokinetics stock price target?

The average 12-month target from 19 analysts is $109.42, 94.9% above the current price of $56.13 Targets range from $78.00 to $146.00.

Is Cytokinetics a buy according to analysts?

The consensus rating is “Strong buy” (7 strong buy, 13 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Cytokinetics expected to earn?

Analysts expect EPS of $-5.76 for the fiscal year ending December 31, 2026 and $-4.23 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.